Glofitamab Plus R-CHOP Induces High Response Rates with a Manageable Safety Profile in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A 12-Month Analysis from a Phase Ib StudyMax S. Topp,Monica Tani,Michael Dickinson,Nilanjan Ghosh,Armando Santoro,Antonio Pinto,Francesc Bosch, Christopher P. Fox,Armando Lopez-Guillermo,Thomas Gastinne,Andreas Viardot,William Townsend,Naseer Qayum,Martin Barrett,Derrick Kaufman,Chun Wu,Ronald McCord,Pauline Baumlin,Patrick Kimes,Franck MorschhauserBLOOD（2023）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
